ONT 0.26% $7.68 1300 smiles limited

you are spot on MarsC: 3 points: 1. Dr Holmes & Dr Hart do...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 554 Posts.
    lightbulb Created with Sketch. 9
    you are spot on MarsC:

    3 points:
    1. Dr Holmes & Dr Hart do mutually respect each other and know each other well - Dr Hart was one of the first I think to do Dental roll-ups and he made a fortune when he sold it to PE or other investors
    2. OVN is a direct competitor to Somnomed and to a less extent (some overlap for mild cases) with RMD/FPH but ONT would negotiate much better deals (margins/commissions $$$) with OVN than an established player. RMD/FPH CPAP machines are sold by doctors, so cant be sold by dentists.
    3. Training dentists to identify high margin cross-sell opportunities i.e. when patients complain about not sleeping due to blocked airways has a massive return on investment and minimal capex.
 
watchlist Created with Sketch. Add ONT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.